Trusted Resources

Amyloidosis: Treatment Options
The most effective treatment for amyloidosis is to treat and control the underlying disease, if there is one. This section tells you the treatments that are the…
Read more
Standardization of 99m technetium Pyrophosphate Imaging Methodology to Diagnose TTR Cardiac Amyloidosis
Background: Technetium pyrophosphate (99mTc-PYP) imaging to diagnose transthyretin cardiac amyloidosis (ATTR-CA) has been increasingly utilized. The objective of…
Read more
Daratumumab-Based Therapies in Patients With AL Amyloidosis
Background: Treatment options for patients (pts) with relapsed/refractory (RR) AL amyloidosis are limited. Daratumumab (dara) has been approved as monotherapy (DMT…
Read more
AL Amyloidosis: From Molecular Mechanisms to Targeted Therapies
Systemic amyloidosis is caused by misfolding and extracellular deposition of circulating proteins as amyloid fibrils, resulting in the dysfunction of vital organs.…
Read more
Cardiac Amyloidosis: An Update on Diagnosis and Treatment
Cardiac amyloidosis (CA), once thought to be a rare disease, is increasingly recognized due to enhanced clinical awareness and better diagnostic imaging. CA is…
Read more
Subscribe to